[1]邱思婕,李新梅.平肝化痰法联合西药治疗老年高血压疗效及对患者血压变异性、臂踝脉搏波传导速度、踝臂指数的影响[J].陕西中医,2021,(8):1056-1059.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.017]
　QIU Sijie,LI Xinmei.Clinical curative effect of Pinggan Huatan method combined with western medicine on elderly hypertension and its influences on blood pressure variability,brachial-ankle pulse wave velocity and ankle-brachial index[J].,2021,(8):1056-1059.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.017]
点击复制

平肝化痰法联合西药治疗老年高血压疗效及对患者血压变异性、臂踝脉搏波传导速度、踝臂指数的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年8期
页码:
1056-1059
栏目:
临床研究
出版日期:
2021-08-05

文章信息/Info

Title:
Clinical curative effect of Pinggan Huatan method combined with western medicine on elderly hypertension and its influences on blood pressure variability,brachial-ankle pulse wave velocity and ankle-brachial index
作者:
邱思婕; 李新梅
(广东省中医院综合二科,广东 番禺 510006)
Author(s):
QIU Sijie; LI Xinmei
(General Second Department of Guangdong Provincial Hospital of Traditional Chinese Medicine,Panyu 510006,China)
关键词:
高血压;  平肝化痰法;  C反应蛋白;  踝臂指数;  臂踝脉搏波传导速度;  血压变异性
Keywords:
Hypertension;  Pinggan Huatan method;  C-reactive protein;  Ankle-brachial index;  Brachial-ankle pulse wave velocity;  Blood pressure variability
分类号:
R 544.1
DOI:
DOI:10.3969/j.issn.1000-7369.2020.08.017
文献标志码:
A
摘要:
目的:探讨平肝化痰法联合西药治疗老年高血压临床疗效及对患者血压变异性、臂踝脉搏波传导速度、踝臂指数的影响。方法:对100例老年高血压患者的临床资料进行回顾性分析,按照治疗方法分为治疗组54例和对照组46例,对照组给予口服氨氯地平片治疗,治疗组采用平肝化痰法联合西药治疗。比较两组临床疗效、血压变化情况、治疗前后血清C反应蛋白、踝臂指数(ABI)、臂踝脉搏波传导速度(BaPWV)。结果:两组临床治疗总有效率分别为92.59%、78.26%,治疗组优于对照组(P<0.05); 治疗组治疗后舒张压(DBP)、收缩压(SBP)均低于对照组(P<0.05); 治疗组治疗后24 h、白昼及夜间舒张压变异性、收缩压变异性均低于对照组(P<0.05); 治疗组治疗后C反应蛋白、BaPWV均低于对照组,ABI高于对照组(P<0.05)。结论:平肝化痰法联合西药治疗能改善老年高血压患者的血压水平,调节炎症反应,降低血压变异性,降低臂踝脉搏波传导速度、踝臂指数。
Abstract:
Objective:To explore the clinical curative effect of Pinggan Huatan method combined with western medicine on elderly hypertension and its influences on blood pressure variability,brachial-ankle pulse wave velocity and ankle-brachial index.Methods:The clinical data of 100 elderly patients with hypertension were retrospectively analyzed.According to different treatment methods,they were divided into treatment group(n=54)and control group(n=46).The control group was treated with routine western medicine,while treatment group was treated with Pinggan Huatan method and western medicine.The clinical curative effect,changes of blood pressure,C-reactive protein,ABI and BaPWV before and after treatment were compared between the two groups.Results:The total response rate of clinical treatment in treatment group was better than that in control group(92.59% vs. 78.26%,P<0.05).After treatment,diastolic blood pressure(DBP)and systolic blood pressure(SBP)in treatment group were lower than those in control group(P<0.05).After treatment,day diastolic blood pressure variability(dDBPV),day systolic blood pressure variability(dSBPV),night diastolic blood pressure variability(nDBPV),night systolic blood pressure variability(nSBPV),24 h diastolic blood pressure variability(24 hDBPV)and 24 h systolic blood pressure variability(24 hSBPV)in treatment group were lower than those in control group(P<0.05).After treatment,C-reactive protein and BaPWV in treatment group were lower than those in control group,while ABI was higher than that in control group(P<0.05).Conclusion:Pinggan Huatan method combined with western medicine can improve blood pressure level in elderly patients with hypertension,reduce blood pressure variability,adjust inflammatory response,decrease ABI and baPWV.

参考文献/References:

[1] 侯红霞,张春红.熄风通络汤联合西药治疗对高血压患者血管内皮功能的影响[J].陕西中医,2019,40(7):875-878.
[2] 蒋 悦,王 琦.硝苯地平与富马酸比索洛尔联合使用治疗中青年高血压疗效及安全性观察[J].中国血液流变学杂志,2020,30(1):53-55,138.
[3] 杨 征,王 毅,范瑾依,等.替米沙坦联合小剂量氨氯地平对高血压患者血管内皮生长因子及血清脂联素的影响[J].陕西医学杂志,2019,48(6):791-793.
[4] 刘宁宁,张铁军,郝菲凡,等.半夏白术天麻汤治疗痰湿壅盛型高血压机制探讨[J].河北中医药学报,2020,35(4):40-43,57.
[5] 雍苏南,谭元生.高血压病中医证型分布规律及合并病的相关性研究[J].辽宁中医杂志,2018,45(5):914-916,1117.
[6] 叶桃春,段 骄,刘敏超,等.平肝潜阳、益气化痰法治疗高血压病眩晕[J].中医杂志,2018,59(2):163-165.
[7] 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-743.
[8] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:73-77.
[9] 侯利红,殷艳玲.硝苯地平联合复方罗布麻颗粒治疗原发性高血压疗效研究[J].陕西医学杂志,2018,47(11):1483-1486.
[10] 姜 北,胡元会,张安晶,等.五苓散联合苯磺酸氨氯地平片治疗痰湿壅盛型高血压[J].世界中医药,2020,15(4):613-616.
[11] 戴朝博.养肝益水方治疗1级高血压疗效及对患者血压变异性的影响[J].陕西中医,2020,41(8):1062-1065.
[12] 王 飞,谢宜静,章 莹.高血压与阴虚体质的相关性研究进展[J].中医药通报,2020,19(2):70-72.
[13] 刘 丹,方 锐,段吾磊,等.中老年高血压证候分布规律及其相关因素分析[J].中国中医基础医学杂志,2018,24(3):351-354.
[14] 郭春霞,陈震霖.中医从心肝肾论治高血压病现代作用机制及优势探讨[J].陕西中医,2020,41(5):650-652,666.
[15] 徐三彬,肖 晓,倪建俐.化痰祛瘀方治疗痰瘀夹杂证H型高血压的临床研究[J].中西医结合心脑血管病杂志,2020,18(4):545-548.
[16] 毕 莹,赵 源,李知晓,等.中药女贞子的研究进展[J].吉林中医药,2019,39(8):1117-1120.
[17] 谭真真,刘 颖,马丽杰.基于网络药理学的枸杞子药理作用及其机制研究[J].中国医药导刊,2020,22(1):28-33.
[18] 于 凡,孙 乐,许利嘉,等.决明子现代应用的研究进展[J].中国现代中药,2018,20(5):626-630.
[19] 路 娟,王 敏,王朋朋.黄连温胆汤加减联合缬沙坦治疗高血压合并高脂血症疗效观察[J].海南医学,2018,29(24):3439-3442.
[20] 袁晓冬,邓建松,刘志高.黄芪联合丹参川芎嗪注射液对老年高血压肾病患者肾功能及炎性因子的影响[J].中国老年学杂志,2020,40(16):3493-3495.
[21] 李建伟,张 婕,王 曼,等.高血压前期人群血压昼夜节律与中性粒细胞淋巴细胞比值的关系研究[J].陕西医学杂志,2020,49(10):1283-1287.

相似文献/References:

[1]杨 敏,姜钧文,肖 蕾.中医体质与急性心肌梗死及其危险因素的相关性研究*[J].陕西中医,2019,(4):437.
　YANG Min,JIANG Junwen,XIAO Lei..Study on the correlation between constitution of traditional Chinese medicine and acute myocardial infarction and its risk factors[J].,2019,(8):437.
[2]高京宏,于 龙 △,王翠娟.大秦艽汤治疗颈椎病性高血压临床研究[J].陕西中医,2019,(5):597.
　GAO Jinghong,YU Long,WANG Cuijuan..Clinical observation of Daqinjiao decoction in the treatment of cervical spondylotic hypertension[J].,2019,(8):597.
[3]侯红霞,张春红.熄风通络汤联合西药治疗对高血压患者血管内皮功能的影响*[J].陕西中医,2019,(7):875.
　HOU Hongxia,ZHANG Chunhong..Effects of Xifeng Tongluo decoction combined with western medicine on vascular endothelial function in patients with hypertension[J].,2019,(8):875.
[4]钱卫东,侍煜景△.宁脉安神颗粒治疗女性更年期高血压疗效及对患者中医证候、血压变异性的影响*[J].陕西中医,2019,(9):1202.
　QIAN Weidong,SHI Yujing..Effects of Ningmai Anshen granule on TCM syndrome and blood pressure variability in women with climacteric hypertension[J].,2019,(8):1202.
[5]郭春霞,陈震霖△.中医从心肝肾论治高血压病现代作用机制及优势探讨*[J].陕西中医,2020,(5):650.[doi:DOI:10.3969/j.issn.10007369.2020.05.027]
　GUO Chunxia,CHEN Zhenlin..Study on Modern mechanism and advantage of TCM treating hypertension on aspects of the heart,liver and kidney[J].,2020,(8):650.[doi:DOI:10.3969/j.issn.10007369.2020.05.027]
[6]钟 路,尹胡海,黄 婕,等.从热毒学说论治高血压*[J].陕西中医,2020,(8):1131.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.032]
　ZHONG Lu,YIN Huhai,HUANG Jie,et al.Treatment of hypertension by heat toxicology[J].,2020,(8):1131.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.032]
[7]朱舜明,张学军,张荣怀,等.生脉注射液联合靶剂量比索洛尔对高血压伴心力衰竭患者血管内皮功能和心功能的影响*[J].陕西中医,2020,(10):1403.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.017]
　ZHU Shunming,ZHANG Xuejun,ZHANG Ronghuai,et al.Effects of Shengmai injection combined with target dose bisoprolol on vascular endothelial function and cardiac function in patients with hypertension and heart failure[J].,2020,(8):1403.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.017]
[8]欧阳雅蓉,傅为武,黄彩依,等.自噬在高血压靶器官损害中的作用及中医药治疗研究进展*[J].陕西中医,2020,(11):1669.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.040]
[9]王辞晓,赵良斌,黄佑群.益气活血补肾方联合厄贝沙坦对高血压性肾损害患者肾功能的保护作用[J].陕西中医,2021,(6):735.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.014]
　WANG Cixiao,ZHAO Liangbin,HUANG Youqun.Protective effect of Yiqi Huoxue Bushen recipe combined with irbesartan on renal function in patients with hypertensive renal damage[J].,2021,(8):735.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.014]
[10]舒 娅,杨华元.中医时间医学在针刺治疗高血压中的降压作用研究进展[J].陕西中医,2021,(10):1483.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.042]

备注/Memo

备注/Memo:
基金项目:广东省中医药局中医药科研项目(20202084)
更新日期/Last Update: 2021-08-09